Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.8209
-0.1084 (-11.66%)
At close: Jun 27, 2025, 4:00 PM
0.8260
+0.0051 (0.62%)
After-hours: Jun 27, 2025, 7:54 PM EDT
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 103 employees as of December 31, 2024. The number of employees decreased by 182 or -63.86% compared to the previous year.
Employees
103
Change (1Y)
-182
Growth (1Y)
-63.86%
Revenue / Employee
$303,039
Profits / Employee
-$1,721,369
Market Cap
298.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LXRX News
- 4 days ago - Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 9 days ago - Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 4 weeks ago - Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology - GlobeNewsWire
- 6 weeks ago - Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 7 weeks ago - Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire